Bcel stock forecast.

The shares of micro-cap biotech, Atreca (BCEL +46.1%) have added more than a third in morning hours on Friday after the company updated early-stage data for its lead cancer candidate ATRC-101 with ...

Bcel stock forecast. Things To Know About Bcel stock forecast.

Analyst Ratings of ATRECA INC - A(NASDAQ:BCEL) stock. Analyst ratings, forecast, price target, upgrades and ... Analysts have set a mean price target forecast of 3.32. This target is 1406.82 ... seem to be have mildly positive about BCEL. In the previous month the buy percentage consensus was at a similar level. BCEL was analyzed by 13 analysts ...Atreca, Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Atreca, Inc. Stock | BCEL | US04965G1094Atreca Inc - Class A Stock Chart and Share Price Forecast, Short-Term "BCEL" Stock Prediction for Next Days and Weeks Walletinvestor.com Atreca Inc - Class A (BCEL) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the July 20, 2020 when the stock price was at 15.10$.. In the short term (2weeks), BCEL's stock price should outperform the market by 2.41%.During that period the price should oscillate between -10.29% and +13.88%.. In the medium term (3months), BCEL's stock …Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.

NSD:BCEL Detailed Stock Analysis, Stock Price Forecast, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes. About Us ... Based on the Atreca Inc stock forecast from 3 analysts, the average analyst target price for Atreca Inc is USD 1.00 over the next 12 months.

BCEL Stock 12 Months Forecast. $2.00. (790.87% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Atreca in the last 3 months. The average price target is $2.00 with a high forecast of $2.00 and a low forecast of $2.00. The average price target represents a 790.87% change from the last price of $0.22.11.85 %. The 3 Wall Street analysts offering Atreca stock forecast in the last 6 months have average price target of $9.0 with a high forecast of $25.0 and a low forecast of $1.0. The average Atreca stock forecast represents a 3729.79% increase from the last price of $0.234999999403953. From AI system, total return is 2366.52% from 4098 forecasts.

Nov 1, 2023 · According to analyst projections, BCEL’s forecast low is $1.00 with $9.00 as the target high. To hit the forecast high, the stock’s price needs a -4185.71% plunge from its current level, while the stock would need to soar -376.19% for it to hit the projected low. Atreca Inc (BCEL) estimates and forecasts About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Wall Street Stock Market & Finance report, prediction for the future: You'll find the Li Auto Inc - ADR share forecasts, stock quote and buy / sell signals below. According to present data Li Auto Inc - ADR's LI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business. At the time of writing, Atreca Inc [BCEL] stock is trading at $0.21, saw in change for the day. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The BCEL shares have gain 4.79% over the last week, with a monthly amount drifted -4.55%, and

May 10, 2023 · On May 10, 2023, Atreca (NASDAQ:BCEL) announced its financial results for the first quarter of the year. The company reported Atreca Reports Q1 2023 Financial Results with Exceeding Analyst Estimates - Best Stocks

Atreca (BCEL) Insider Trading Activity 2023. All the trading advice you’ve ever received boils down to this (Ad) How major US stock indexes fared Friday, 12/1/2023. US targets oil and natural gas industry's role in global warming with new rule on methane emissions. S&P 500 4,594.63. DOW 36,245.50.

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Track Atreca Inc - Ordinary Shares - Class A (BCEL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Allakos Inc have a median target of 9.50, with a high estimate of 22.00 and a low estimate of 1.50. The median estimate ...According to the issued ratings of 5 analysts in the last year, the consensus rating for Atreca stock is Hold based on the current 4 hold ratings and 1 buy rating for …

Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ...Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ... BCEL BCEL Atreca Inc - Ordinary Shares - Class A 2,464 Watch Alerts $0.223 $0.0092 (4.30%) Today $0.23 0.0035 (1.57%) After Hours About Feed News Sentiment Earnings …Nov 16, 2023 · Analysts have been projecting $1.00 as a low price target for the stock while placing it at a high target of $9.00. It follows that stock’s current price would drop -4400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -400.0% for stock’s current value. Atreca Inc (BCEL) estimates and forecasts Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 2.50. The median ...

Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Allakos Inc have a median target of 9.50, with a high estimate of 22.00 and a low estimate of 1.50. The median estimate ...

Atreca Inc [BCEL] stock prices are down -14.82% to $0.28 at the moment. ... An investor can expect a potential return of 1060.71% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In this publicly-traded organization, revenue per employee is $8,556, ...Apr 6, 2023 · Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the ... Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25.The average Morphic Holding stock price prediction forecasts a potential upside of 124.84% from the current MORF share price of $23.72. What is MORF's forecast return on equity (ROE) for 2023-2025? (NASDAQ: MORF) forecast ROE is -29.51%, which is considered weak.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Cymabay Therapeutics's CBAY shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).Find real-time VCEL - Vericel Corp stock quotes, company profile, news and forecasts from CNN Business.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Hudbay Minerals share forecasts, stock quote and buy / sell signals below. According to present data Hudbay Minerals's HBM shares and potentially its market environment have been in bearish cycle last 12 months (if exists).NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Find the latest Keurig Dr Pepper Inc. (KDP) stock quote, history, news and other vital information to help you with your stock trading and ...

Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response.

Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BCEL stock returns are also predicted based on historical data. According to our research, BCEL stock is a bad long-term investment. BCEL share price has been in a bear cycle for the past year. Atreca, Inc. stock trend is negative .

A treca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...HOOK Stock 12 Months Forecast. $6.83. (1382.20% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Hookipa Pharma in the last 3 months. The average price target is $6.83 with a high forecast of $7.00 and a low forecast of $6.50. The average price target represents a 1382.20% change from the last price of $0.46.Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin. The current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.Analyst Forecast. According to 5 analysts, the average rating for BCEL stock is "Hold." The 12-month stock price forecast is $3.38, which is an increase of …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cheniere Energy share forecasts, stock quote and buy / sell signals below. According to present data Cheniere Energy's LNG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Track Atreca Inc - Ordinary Shares - Class A (BCEL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsStocks & ETFs, MFs & FOREX. AI Trend Prediction Engine. Stocks & ETFs, MFs & FOREX12 brokerages have issued 1-year price targets for CymaBay Therapeutics' stock. Their CBAY share price targets range from $12.00 to $34.00. On average, they expect the company's stock price to reach $22.27 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts price targets for …

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below. According to present data Coterra Energy's CTRA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Atreca Inc have a median target of 1.50, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +500.00% increase from the last price of 0.25. In 2021 and 2020, respectively 14 and 13 companies raised sums of $250m or more, whilst in 2019 and 2018, the numbers were 3 and 2. Atreca Inc ( NASDAQ: BCEL) IPOd in June 2019, raising ~$114m at ...According to the issued ratings of 9 analysts in the last year, the consensus rating for Hudbay Minerals stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for HBM. The average twelve-month price prediction for Hudbay Minerals is C$9.18 with a high price target of C$10.50 and a low price target of C$8.00.Instagram:https://instagram. sensetime stockekoparkunder 10 dollar stocksotcmkts saenf Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Allakos Inc have a median target of 9.50, with a high estimate of 22.00 and a low estimate of 1.50. The median estimate ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get... best app for trading futurestop cyber security company Here's Why Atreca, Inc. (BCEL) Is a Great 'Buy the Bottom' Stock Now Zacks - Thu Apr 6, 8:55AM CDT . Atreca, Inc. (BCEL) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall...Average. $3.25. Current Price. $0.21. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ... pre ipo trading platform Explore BCEL - Atreca Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to 2050This reflects a positive earnings surprise of 12.50%. Look out for BCEL's next earnings release expected on November 09, 2023. For the next earning release, we expect the company to report ...